CeriBell, Inc (CBLL) - Cash Flow Conversion Efficiency
Based on the latest financial reports, CeriBell, Inc (CBLL) has a cash flow conversion efficiency ratio of -0.100x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-12.86 Million) by net assets ($128.31 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see how much is CeriBell, Inc worth for the company's overall valuation and market capitalisation.
CeriBell, Inc - Cash Flow Conversion Efficiency Trend (2022–2025)
This chart illustrates how CeriBell, Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.
CeriBell, Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of CeriBell, Inc ranked by their cash flow conversion efficiency. See how well can CeriBell, Inc service its debt to evaluate how effectively operating cash flow covers total debt obligations.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Lithium Argentina AG
NYSE:LAR
|
-0.008x |
|
KSB SE & Co. KGaA
XETRA:KSB
|
0.109x |
|
Nsfocus Information Technology Co Ltd
SHE:300369
|
-0.005x |
|
WAM Capital Ltd
AU:WAM
|
0.063x |
|
Rongan Property Co Ltd
SHE:000517
|
0.074x |
|
Barings BDC Inc
NYSE:BBDC
|
0.014x |
|
Sichuan Jinshi Technology Co Ltd Class A
SHE:002951
|
-0.004x |
|
Hunan Keli Motor Co Ltd
SHE:002892
|
0.043x |
Annual Cash Flow Conversion Efficiency for CeriBell, Inc (2022–2025)
The table below shows the annual cash flow conversion efficiency of CeriBell, Inc from 2022 to 2025. View today's stock price for CeriBell, Inc for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $155.34 Million | $-40.81 Million | -0.263x | -43.31% |
| 2024-12-31 | $191.16 Million | $-35.04 Million | -0.183x | -170.57% |
| 2023-12-31 | $-112.25 Million | $-29.16 Million | 0.260x | -29.87% |
| 2022-12-31 | $-86.40 Million | $-32.00 Million | 0.370x | -- |
About CeriBell, Inc
CeriBell, Inc. operates as a medical technology company in the United States. It develops the Ceribell System, a novel and point-of-care EEG platform specifically designed to address the unmet needs of patients in the acute care setting. The company also offers disposable, flexible headbands, and headcaps; and a pocket-sized, rechargeable battery-operated recorder used to capture and wirelessly t… Read more